“Spot-on” evidence-based urological nursing care New research and developments
Dear EAUN members,
Stefano Terzoni, Chair EAUN Special Interest Group – Continence s.terzoni@eaun.org
Mortality Among Patients with Bladder Cancer – A Randomized Clinical Trial. JAMA. 2022;327(21):2092- 2103. doi:10.1001/jama.2022.7393. https://pubmed.ncbi.nlm.nih.gov/35569079/ • N ottingham CU, Large T, Agarwal DK, Rivera ME, Krambeck AE. Comparison of Newly Optimized Moses Technology vs Standard Holmium:YAG for Endoscopic Laser Enucleation of the Prostate. J Endourol. 2021 Sep;35(9):1393-1399. doi: 10.1089/end.2020.0996. Epub 2021 Jul 15. PMID: 33813861. https://pubmed.ncbi.nlm.nih.gov/33813861/ Bladder cancer • L obo et al. Epidemiology, Screening, and Prevention of Bladder Cancer. European Urology Oncology vol 5, issue 6 pg 628-639 Dec 2022 https://doi.org/10.1016/j.euo.2022.10.003 • B acon et al. Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy. European Urology Oncology vol 5, issue 6 pg 677-686 Dec 2022 https://doi.org/10.1016/j.euo.2021.11.002 • P uffelen et al. Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections. Journal for immunotherapy of Cancer. 2023;11:e005518. https://jitc.bmj.com/content/11/1/e005518 • A ngulo et al. Hyperthermic Mitomycin C in Intermediate- risk Non–muscle-invasive Bladder Cancer: Results of the HIVEC-1 Trial. European Urology Oncology vol 6, issue 1 pg 58-66 Feb 2023 https://doi.org/10.1016/j.euo.2022.10.008 • S rihar et al. Predictive Biomarkers in Muscle Invasive Bladder Cancer: Are We There Yet? European Urology. Vol 83. No.4 pg 318-319 April 2023 https://doi.org/10.1016/j.eururo.2022.07.023
• Time to Rethink Quality of Life Assessment in Patients with Urothelial Cancer in the Current Therapeutic Era? European Urology. Vol 83. No.4 pg 329-330 April 2023. https://doi.org/10.1016/j.eururo.2022.04.016 • C han et al. Blue light transurethral resection and biopsy of bladder cancer with hexaminolevulinate: Histopathological characteristics and recurrence rates in a single UK centre study. British Journal of Urology International. BJUI Compass. 2023;1–7 https://doi.org/10.1002/bco2.250 Prostate cancer • C hen W, Li H, Qin N, Zhou J, Ou-Yang J, Wang KY. Effectiveness of couple-based interventions for prostate cancer patients and their spouses on their quality of life: a systematic review and meta-analysis. Support Care Cancer. 2022 Dec 15;31(1):34. PMID: 36517615. https://doi.org/10.1007/s00520-022-07532-2 • K c M, Oral E, Rung AL, Trapido E, Rozek LS, Fontham ETH, Bensen JT, Farnan L, Steck SE, Song L, Mohler JL, Khan S, Vohra S, Peters ES. Prostate cancer aggressiveness and financial toxicity among prostate cancer patients. Prostate. 2023 Jan;83(1):44-55. Epub 2022 Sep 5. PMID: 36063402; PMCID: PMC10087487. https://doi.org/10.1002/pros.24434 • Ø stergaard, LD, Poulsen, MH, Jensen, ME, Lund, L, Hildebrandt, MG, Nørgaard, B. Health-related quality of life the first year after a prostate cancer diagnosis a systematic review. Int J Urol Nurs. 2023; 17( 1): 15- 28. https://doi.org/10.1111/ijun.12340 • W ittmann D, Mehta A, McCaughan E, Faraday M, Duby A, Matthew A, Incrocci L, Burnett A, Nelson CJ, Elliott S, Koontz BF, Bober SL, McLeod D, Capogrosso P, Yap T, Higano C, Loeb S, Capellari E, Glodé M, Goltz H, Howell D, Kirby M, Bennett N, Trost L, Odiyo Ouma P, Wang R,
The growing evidence in urology nursing care is amazing! With this column, the EAUN Special Interest Groups want to put the spotlight on recent publications in their field of interest. This month’s articles have been carefully chosen because of the scientific value from PubMed and other sources and represent different methods and approaches in research and development in urological nursing care. We hope this initiative will have your attention and continuously provide information on “spot-on” urological nursing care. If you would like to inform us and your colleagues about new initiatives or exiting developments in one of the special interest fields you can contact us using the email addresses below. Best regards Anna Mohammed, Chair EAUN Special Interest Group - Endourology a.mohammed@eaun.org
Jeannette Verkerk, Chair EAUN Special Interest Group – Sexual Health j.verkerk@eaun.org
Selected from PubMed
Endourology • G iancarlo Marra, Marco Agnello, Andrea Giordano, Francesco Soria, Marco Oderda, Charles Dariane, Marc-Olivier Timsit, Julien Branchereau, Oussama Hedli, Benoit Mesnard, Derya Tilki, Jonathon Olsburgh, Meghana Kulkarni, Veeru Kasivisvanathan, Alberto Breda, Luigi Biancone, Paolo Gontero. Robotic Radical Prostatectomy for Prostate Cancer in Renal Transplant Recipients: Results from a Multicenter Series. European Urology 2022;(82)6:639-645.
https://doi.org/10.1016/j.eururo.2022.05.024. https://pubmed.ncbi.nlm.nih.gov/35750583/
• E ugenio Ventimiglia, Christian Corsini, Francesco Montorsi, Andrea Salonia, Ioannis Kartalas Goumas. A Randomized, Single-blind Clinical Trial Comparing Robotic-assisted Fluoroscopic-guided with Ultrasound- guided Renal Access for Percutaneous Nephrolithotomy. European Urology. 2022;82(6):660-661.
Bente Thoft Jensen, Chair EAUN Special Interest Group - Bladder Cancer b.thoft@eaun.org
https://doi.org/10.1016/j.eururo.2022.08.021. https://pubmed.ncbi.nlm.nih.gov/36163307/
Louisa Fleure, Chair EAUN Special Interest Group – Prostate Cancer l.fleure@eaun.org
• J ames W. F. Catto, Pramit Khetrapal, Frederico Ricciardi, et al (2022) Effect of Robot- Assisted Radical Cystectomy with Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90 – day Morbidity and
Continued on page 50
Table of Contents
European Urology Today June/July 2023
49
Powered by FlippingBook